OBI Pharma, Inc.(TW:4174)
NT$60.50+5.50 (+10.00%)
TW:4174
OBI Pharma, Inc. Revenue
NT$60.50
At close:+5.50 (+10.00%)
OBI Pharma, Inc. (4174) Revenue
OBI Pharma, Inc. Revenue
OBI Pharma, Inc. had a revenue of 15.28M in the quarter ending Jun 30, 2026, with 174.62%. This bring the company's revenue in the last twelve months to 52.20M, Increased 5.08%. In the fiscal year ending Dec 31, 2025, OBI Pharma, Inc. had annual revenue of 58.58M with -6.55% growth.
- Revenue (ttm)
- 52.20M
- Revenue Growth
- -2.20%
- P/S Ratio
- 123.46
- Revenue/Employee
- TWD 225,288
- Employees
- 260
- Market Cap
- TWD 7.23B
Revenue Chart
OBI Pharma, Inc. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 58.58M | -4.10M | -6.55% |
| Dec 31, 2024 | 62.68M | 21.13M | 50.85% |
| Mar 31, 2024 | 41.55M | 36.84M | 781.96% |
| Dec 31, 2022 | 4.71M | -14.06M | -74.90% |
| Dec 31, 2021 | 18.77M | -122.11M | -86.68% |
| Dec 31, 2020 | 140.89M | 140.01M | 16056.65% |
| Dec 31, 2019 | 872.00K | -12.47M | -93.46% |
| Dec 31, 2018 | 13.34M | 12.96M | 3447.61% |
| Dec 31, 2017 | 376.00K | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.